From: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
Train | Validation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AUC | ACC | 95%CI | Sensitivity | Specificity | AUC | ACC | 95%CI | Sensitivity | Specificity | |||
CT _ clinical | ||||||||||||
GP | 0.887 | 0.824 | 0.833–0.933 | 0.820 | 0.831 | 0.795 | 0.793 | 0.635–0.923 | 0.867 | 0.714 | ||
LR | 0.862 | 0.833 | 0.798–0.914 | 0.885 | 0.774 | 0.810 | 0.724 | 0.639–0.916 | 0.800 | 0.643 | ||
PLS-DA | 0.848 | 0.781 | 0.782–0.903 | 0.770 | 0.792 | 0.800 | 0.724 | 0.636–0.914 | 0.733 | 0.714 | ||
CTE _ clinical | ||||||||||||
GP | 0.840 | 0.781 | 0.773–0.896 | 0.820 | 0.736 | 0.843 | 0.828 | 0.697–0.952 | 0.867 | 0.786 | ||
LR | 0.835 | 0.798 | 0.760–0.894 | 0.787 | 0.811 | 0.843 | 0.793 | 0.692–0.949 | 0.733 | 0.857 | ||
PLS-DA | 0.795 | 0.772 | 0.717–0.860 | 0.770 | 0.773 | 0.824 | 0.793 | 0.657–0.938 | 0.867 | 0.714 | ||
ComB _ clinical | ||||||||||||
GP | 0.872 | 0.798 | 0.812–0.919 | 0.738 | 0.868 | 0.824 | 0.759 | 0.676–0.929 | 0.800 | 0.714 | ||
LR | 0.869 | 0.781 | 0.811–0.919 | 0.803 | 0.736 | 0.833 | 0.793 | 0.688–0.938 | 0.800 | 0.786 | ||
PLS-DA | 0.852 | 0.763 | 0.789–0.905 | 0.738 | 0.717 | 0.843 | 0.828 | 0.697–0.952 | 0.800 | 0.857 |